Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shota Myojin
Observed name:
明神,翔太
Institution:
National Center For Child Health and Development
Observed institutions:
Nihon University,
National Center For Child Health and Development,
Himeji Red Cross Hospital,
Tokyo Metropolitan Children's Medical Center
ORCID:
0000-0001-5919-0919
Observed ORCID:
0000-0001-5919-0919
OpenAlex ID:
A5036893326
Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population-based matched case control study
2022
·
Shota Myojin
, Kyongsun Pak
, et al.
·
PLoS ONE
·
16
Pyogenic spondylitis and paravertebral abscess caused by Salmonella Saintpaul in an immunocompetent 13-year-old child: a case report
2018
·
Shota Myojin
, Naohiro Kamiyoshi
, et al.
·
BMC Pediatrics
·
12
PDF
Safety of and antibody response to the BNT162b2 COVID-19 vaccine in adolescents and young adults with underlying disease
2022
·
Kensuke Shoji
, Takanori Funaki
, et al.
·
Journal of Infection and Chemotherapy
·
10
PDF
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child
2018
·
Shota Myojin
, Kahoru Fukuoka
, et al.
·
International Journal of Infectious Diseases
·
9
Trend in antibiotic prescription at pediatric primary emergency medical centers in Japan: A multi-center, cross-sectional study
2024
·
Shogo Otake
, Takayo Shoji
, et al.
·
Journal of Infection and Chemotherapy
·
6
PDF
An infant with refractory cytomegalovirus‐induced thrombocytopenia
2019
·
Suguru Uemura
, Takeshi Mori
, et al.
·
Clinical Case Reports
·
6
PDF
Two Cases of Children With Black Hairy Tongue and Tooth Discoloration Caused by Antibacterial Agents
2024
·
Mayumi Yamada
, Kensuke Shoji
, et al.
·
Cureus
·
4
PDF
Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5–11 years with underlying diseases: A prospective observational study
2024
·
Takanori Funaki
, Masaki Yamada
, et al.
·
Journal of Infection and Chemotherapy
·
3
Comparing the effects of antimicrobial stewardship at primary emergency centers
2023
·
Shogo Otake
, Yoshiki Kusama
, et al.
·
Pediatrics International
·
3
PDF
Association between use of antipyretics and antibody titers after two doses of the BNT162b2 SARS-CoV-2 vaccine in adolescents and young adults with underlying diseases
2023
·
Hiroyuki Aiba
, Takanori Funaki
, et al.
·
Journal of Infection and Chemotherapy
·
2
Septic Arthritis Caused by Haemophilus parainfluenzae: A Pediatric Case Report and Literature Review
2023
·
Haruka Fukayama
, Shota Myojin
, et al.
·
The Pediatric Infectious Disease Journal
·
2
Prognostic factors among patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome: A retrospective cohort study using a nationwide inpatient database in Japan
2023
·
Shota Myojin
, Nobuaki Michihata
, et al.
·
Journal of Infection and Chemotherapy
·
2
Antibody titer trends after SARS-CoV-2 vaccination in patients aged 12–25 years with underlying diseases
2024
·
Taketo Kasai
, Masaki Yamada
, et al.
·
Journal of Infection and Chemotherapy
Daptomycin treatment for persistent bacteremia in a pediatric solid organ transplant recipient: Case report and literature review
2024
·
Shota Myojin
, Kensuke Shoji
, et al.
·
Journal of Infection and Chemotherapy
Successful management with urgent haploidentical‐peripheral blood stem cell transplantation for a patient with severe aplastic anaemia who developed disseminated fungal infection following immunosuppressive therapy
2024
·
Norihito Ikenobe
, Kentaro Fujimori
, et al.
·
eJHaem
Interventions for Shiga toxin-producing Escherichia coli gastroenteritis and risk of hemolytic uremic syndrome: A population- based matched case control study
2023
·
明神,翔太
·
Institutional Repositories DataBase (IRDB)
2000. Clinical characteristics and prognosis of patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome and encephalopathy: a nationwide observational study in Japan
2022
·
Shota Myojin
, Nobuaki Michihata
, et al.
·
Open Forum Infectious Diseases
717. Antibiotic treatment of Shiga toxin-producing Escherichia coli related gastroenteritis and the risk of hemolytic uremic syndrome: a population based matched case-control study in Japan
2020
·
Shota Myojin
, Kyongsun Pak
, et al.
·
Open Forum Infectious Diseases
Show more works
View as search
Works count:
18
Citation count:
75
H-index:
6
I10-index:
3
Year
Topic
Type